Search Results 2061-2070 of 2975 for 必应搜索引擎留痕咨询邮箱：lgooxc@hotmail.com

  1. A Phase III, Randomised Study Of Adjuvant Dato-DXd In Combination With Rilvegostomig Or Rilvegostomig Monotherapy Versus Standard Of Care, Following Complete Tumour Resection, In Participants With Stage I Adenocarcinoma NSCLC Who Are CtDNA-positive Or Have High-risk Pathological Features - Mayo Clinic

    A Phase III, Randomised Study Of Adjuvant Dato-DXd In Combination With Rilvegostomig Or Rilvegostomig Monotherapy Versus Standard Of Care, ...

  2. A Study to Identify Risk Factors from any Reason for Hospital Readmission, Death, or Declining Health in Older Persons who were Hospitalized with a Heart Attack - Mayo Clinic

    Information will be collected on hospital readmissions, death, and decline in health from any cause following a heart attack. The goal is help older people in ...

  3. Pazopanib in Treating Patients with Metastatic Non-Clear Cell Kidney Cancer - Mayo Clinic

    Pazopanib hydrochloride may also stop the growth of kidney cancer by blocking blood flow to the tumor. Participation eligibility. Participant eligibility ...

  4. Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery - Mayo Clinic

    This randomized phase III trial has several primary objectives. One primary objective is to compare the efficacy of 3 different endocrine therapies, the ...

  5. AMG v EMG with Tucked Arms - Mayo Clinic

    The primary aim of this study is to evaluate accuracy and precision of simultaneous acceleromyograph and electromyograph in unparalyzed patients. Participation ...

  6. A Randomized Study of Approaches in Total Hip Arthroplasty - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. A Study to Evaluate the Safety and Effectiveness of TT-00420 in Adults with Advanced Cholangiocarcinoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of Persistent Post-Traumatic Headache (PPTH) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Dose Titration Study to Assess the Effects of SAR407899 in Patients With Microvascular Angina and/or Persistent Stable Angina Despite Angiographically Successful Elective PCI - Mayo Clinic

    - To assess SAR407899 plasma concentrations in microvascular angina patients and/or persistent stable angina despite angiographically successful elective PCI.

  10. Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients - Mayo Clinic

    This study is to evaluate which cognitive-linguistic symptoms are most commonly experienced following brain tumor treatment. Cognitive surveys will be ...